The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
International Glaucoma Association
15A Highpoint Business Village
Kent, TN24 8DH
The International Glaucoma Association (IGA) is an international voluntary organization in the United Kingdom dedicated to offering advice and support to individuals with glaucoma, increasing public awareness, campaigning for improved services for affected individuals, and supporting clinical research. The association's aim is to prevent the loss of sight from glaucoma throughout the world through establishment of an international membership and cooperation with similar societies that have the same objectives. Glaucoma is a group of eye disorders in which abnormally increased pressure of the fluid of the eye damages the optic nerve, resulting in visual impairment. The optic nerve transmits visual impulses from the nerve-rich, light-sensitive membrane lining the eyes (retinas) to the brain. The International Glaucoma Association was established in 1974 and currently has over 15,000 members in approximately 60 countries. The association campaigns for improved detection methods for those at risk for glaucoma; responds to thousands of information requests each year via phone, fax, mail, and e-mail; provides networking opportunities for affected individuals and family members; and conducts regular discussion forums.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.